Dr. Rohit Jain, MD, MPH
Claim this profileMoffitt Cancer Center
Area of expertise
Bladder Cancer
Rohit Jain, MD, MPH has run 6 trials for Bladder Cancer. Some of their research focus areas include:
Transitional Cell Carcinoma
Rohit Jain, MD, MPH has run 4 trials for Transitional Cell Carcinoma. Some of their research focus areas include:
Affiliated Hospitals
Moffitt Cancer Center
H. Lee Moffitt Cancer Center And Research Institute
Clinical Trials Rohit Jain, MD, MPH is currently running
Modified Immune Cells
for Prostate Cancer
This is a phase 1 single center clinical trial for patients with end stage Metastatic Castration Resistant Prostate Cancer who have progressed through standard of care treatment options and are on zoledronate for bone metastases. This clinical trial includes a dose-escalation phase and dose-expansion phase to assess the safety and preliminary efficacy of treatment with autologous T cells genetically modified to express Prostate stem cell antigen.
Recruiting
1 award
Phase 1
Disitamab Vedotin + Pembrolizumab
for Bladder Cancer
This trial is testing a new drug called disitamab vedotin, alone or with pembrolizumab, for patients with advanced or metastatic HER2 expressing bladder cancer. Disitamab vedotin is designed to target HER2 and has been approved for other types of cancer. The study aims to see if these drugs can effectively treat the cancer and what side effects they might cause.
Recruiting
1 award
Phase 2
4 criteria
More about Rohit Jain, MD, MPH
Clinical Trial Related
4 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Rohit Jain, MD, MPH has experience with
- Nivolumab
- Pembrolizumab
- Enfortumab Vedotin
- Erdafitinib
- CG0070
- Ipilimumab
Breakdown of trials Rohit Jain, MD, MPH has run
Bladder Cancer
Transitional Cell Carcinoma
Urothelial Carcinoma
Kidney Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rohit Jain, MD, MPH specialize in?
Rohit Jain, MD, MPH focuses on Bladder Cancer and Transitional Cell Carcinoma. In particular, much of their work with Bladder Cancer has involved Stage III patients, or patients who are Stage IV.
Is Rohit Jain, MD, MPH currently recruiting for clinical trials?
Yes, Rohit Jain, MD, MPH is currently recruiting for 2 clinical trials in Tampa Florida. If you're interested in participating, you should apply.
Are there any treatments that Rohit Jain, MD, MPH has studied deeply?
Yes, Rohit Jain, MD, MPH has studied treatments such as Nivolumab, Pembrolizumab, Enfortumab Vedotin.
What is the best way to schedule an appointment with Rohit Jain, MD, MPH?
Apply for one of the trials that Rohit Jain, MD, MPH is conducting.
What is the office address of Rohit Jain, MD, MPH?
The office of Rohit Jain, MD, MPH is located at: Moffitt Cancer Center, Tampa, Florida 33612 United States. This is the address for their practice at the Moffitt Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.